0
Business
Novo-Backed Biotech Hemab Raises $301.5 Million in Upsized IPO
April 30, 2026
Scroll
Posted 3 hours ago by
Hemab Therapeutics Holdings Inc., a clinical-stage biotechnology company that counts Novo Nordisk Foundation as one of its biggest investors, raised 301.5 million in an upsized US initial public offering that priced at the top of a marketed range.
Bloomberg
Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.
United States of America
Bias: lean left
People's Voices (0)
Leave a comment
0/500
Note: Comments are moderated. Please keep it civil. Max 3 comments per day.